These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18481219)

  • 1. Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa.
    Cernohorská L; Votava M
    Folia Microbiol (Praha); 2008; 53(1):57-60. PubMed ID: 18481219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa.
    Song W; Woo HJ; Kim JS; Lee KM
    Int J Antimicrob Agents; 2003 Jan; 21(1):8-12. PubMed ID: 12507832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming Pseudomonas aeruginosa strains.
    Kádár B; Szász M; Kristóf K; Pesti N; Krizsán G; Szentandrássy J; Rókusz L; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2010 Sep; 57(3):235-45. PubMed ID: 20870595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
    Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
    Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of pomegranate and rosemary extracts in combination with antibiotics against antibiotic resistance and biofilm formation of Pseudomonas aeruginosa.
    Abu El-Wafa WM; Ahmed RH; Ramadan MA
    Braz J Microbiol; 2020 Sep; 51(3):1079-1092. PubMed ID: 32394240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa.
    Weiss K; Lapointe JR
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2411-4. PubMed ID: 8585718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm.
    Gómez-Junyent J; Murillo O; Yu HH; Azad MAK; Wickremasinghe H; Rigo-Bonnin R; Benavent E; Ariza J; Li J
    Int J Antimicrob Agents; 2021 Feb; 57(2):106246. PubMed ID: 33253904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of multidrug-resistant Pseudomonas aeruginosa isolated from drinking water and hospitalized patients in Jordan.
    Tarazi YH; Abu-Basha E; Ismail ZB; Al-Jawasreh SI
    Acta Trop; 2021 May; 217():105859. PubMed ID: 33582141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dependence of biofilm-forming ability on the antibiotic sensitivity of Pseudomonas aeruginosa clinical strains isolated from patients with chronic osteomyelitis.].
    Shipitsyna IV; Osipova EV; Ovchinnikov EN; Leonchuk DS
    Klin Lab Diagn; 2020; 65(1):37-41. PubMed ID: 32155005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections].
    Cernohorská L; Sláviková P
    Epidemiol Mikrobiol Imunol; 2009 Nov; 58(4):154-7. PubMed ID: 21114003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
    Mayer I; Nagy E
    J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa.
    Abdi-Ali A; Mohammadi-Mehr M; Agha Alaei Y
    Int J Antimicrob Agents; 2006 Mar; 27(3):196-200. PubMed ID: 16459057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E; Zer Y; Eksi F
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.
    Giamarellou H; Zissis NP; Tagari G; Bouzos J
    Antimicrob Agents Chemother; 1984 Apr; 25(4):534-6. PubMed ID: 6428310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.